New business venture focused on generics in Japan to be established in or after April 2016; owned 51% by Teva and 49% by Takeda

Source Link:

http://www.tevapharm.com/news/inserting_and_replacing_takeda_provides_further_information_about_its_new_business_venture_with_teva_12_15.aspx